Indomethacin Prophylaxis for Preterm Infants: The Impact of 2 Multicentered Randomized Controlled Trials on Clinical Practice

Journal of Pediatrics

Volumn 150, Issue 1, 2007, Pages

  Clyman, Ronald I ^a   Saha, Shampa ^a   Jobe, Alan ^a   Oh, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ARTICLE; BRAIN HEMORRHAGE; CLINICAL PRACTICE; HUMAN; INFANT; MAJOR CLINICAL STUDY; METHODOLOGY; NERVOUS SYSTEM DEVELOPMENT; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; PUBLICATION; SOMATOSENSORY DISORDER; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 33845643692     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.09.001     Document Type: Article

References (28)

1. Schmidt B., Asztalos E.V., Roberts R.S., Robertson C.M., Sauve R.S., and Whitfield M.F. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely-low-birth weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 289 (2003) 1124-1129
2. Laptook A.R., O'Shea T.M., Shankaran S., and Bhaskar B. Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalence and antecedents. Pediatrics 115 (2005) 673-680
3. Vohr B.R., Wright L.L., Dusick A.M., Mele L., Verter J., Steichen J.J., et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 105 (2000) 1216-1226
4. Vohr B., Garcia Coll C., Flanagan P., and Oh W. Effects of intraventricular hemorrhage and socioeconomic status on perceptual, cognitive, and neurologic status of low birth weight infants at 5 years of age. J Pediatr 121 (1992) 280-285
5. Piecuch R.E., Leonard C.H., Cooper B.A., Kilpatrick S.J., Schlueter M.A., and Sola A. Outcome of infants born at 24-26 weeks' gestation. II: neurodevelopmental outcome. Obstet Gynecol 90 (1997) 809-814
6. Bandstra E.S., Montalvo B.M., Goldberg R.N., Pacheco I., Ferrer P.L., Flynn J., et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 82 (1988) 533-542
7. Bada H.S., Green R.S., Pourcyrous M., Leffler C.W., Korones S.B., Magill H.L., et al. Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr 115 (1989) 631-637
8. Fowlie P.W., and Davis P.G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (2002) CD000174
9. Ment L.R., Duncan C.C., Ehrenkranz R.A., Kleinman C.S., Pitt B.R., Taylor K.J.W., et al. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very-low-birth weight infants. J Pediatr 107 (1985) 937-943
10. Ment L.R., Duncan C.C., Ehrenkranz R.A., Kleinman C.S., Taylor K.J.W., Scott D.T., et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very-low-birth weight neonates. J Pediatr 112 (1988) 948-955
11. Ment L.R., Oh W., Ehrenkranz R.A., Philip A.G., Vohr B., Allan W., et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 93 (1994) 543-550
12. Ment L.R., Oh W., Ehrenkranz R.A., Phillip A.G., Vohr B., Allan W., et al. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 124 (1994) 951-955
13. Edwards A.D., Wyatt J.S., Richardson C., Potter A., Cope M., Delpy D.T., et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 335 (1990) 1491-1495
14. Leffler C.W., Busija D.W., Fletcher A.M., Beasley D.G., Hessler J.R., and Green R.S. Effects of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res 19 (1985) 1160-1164
15. Saliba E., Chantepie A., Autret E., Gold F., Pourcelot L., and Laugier J. Effects of indomethacin on cerebral hemodynamics at rest and during endotracheal suctioning in preterm neonates. Acta Paediatr Scand 80 (1991) 611-615
16. Schmidt B., Davis P., Moddemann D., Ohlsson A., Roberts R.S., Saigal S., et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344 (2001) 1966-1972
17. Clyman R.I. Commentary. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 128 (1996) 601-607
18. Al Faleh K., Smyth J., Roberts R., Solimano A., Asztalos E., and Schmidt B. Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms (TIPP) [abstract]. Pediatr Res 55 (2004) 456A
19. Hintz S.R., Poole W.K., Wright L.L., Fanaroff A.A., Kendrick D.E., Laptook A.R., et al. Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. Arch Dis Child Fetal Neonatal Ed 90 (2005) F128-F133
20. Volpe J.J. Intraventricular hemorrhage and brain injury in the premature infant: neuropathology and pathogenesis. Clin Perinatol 16 (1989) 361-386
21. Moin F., Kennedy K.A., and Moya F.R. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol 20 (2003) 313-320
22. Brooks J.M., Travadi J.N., Patole S.K., Doherty D.A., and Simmer K. Is surgical ligation of patent ductus arteriosus necessary?. The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 90 (2005) F235-F239
23. Campbell M. Natural history of persistent ductus arteriosus. Br Heart J 30 (1968) 4-13
24. Vohr B.R., Allan W.C., Westerveld M., Schneider K.C., Katz K.H., Makuch R.W., et al. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 111 (2003) e340-e346
25. Miller S.P., Ferriero D.M., Leonard C., Piecuch R., Glidden D.V., Partridge J.C., et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr 147 (2005) 609-616
26. Miller S.P., Mayer E.E., Clyman R.I., Glidden D.V., Hamrick S.E., and Barkovich A.J. Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks' gestation at birth. Pediatrics 117 (2006) 1626-1631
27. Ment L.R., Vohr B., Allan W., Westerveld M., Sparrow S.S., Schneider K.C., et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 105 (2000) 485-491
28. Ment L.R., Vohr B.R., Makuch R.W., Westerveld M., Katz K.H., Schneider K.C., et al. Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. J Pediatr 145 (2004) 832-834